Minapharm Pharmaceuticals (MIPH) Financials
Annual financial statement highlights for Minapharm Pharmaceuticals covering fiscal years 2006–2025. Figures are updated weekly.
| Fiscal year | Revenue | Net income | EPS | Free cash flow | Total assets | Total debt | Dividend per share |
|---|---|---|---|---|---|---|---|
| 2025ended Dec 2025 | 6.44B | 36.62M | 0.60 | -259.11M | 13.15B | 4.52B | 2.50 |
| 2024ended Dec 2024 | 5.6B | 153.47M | 11.59 | -652.19M | 12.01B | 5.55B | 2.50 |
| 2023ended Dec 2023 | 3.89B | -35.14M | -5.01 | -1.29B | 8.7B | 3.78B | 1.65 |
| 2022ended Dec 2022 | 3.62B | 609.51M | 51.41 | -598.44M | 6.81B | 2.43B | 2.80 |
| 2021ended Dec 2021 | 3.01B | 466.41M | 37.94 | -182.1M | 4.11B | 1.25B | 2.92 |
| 2020ended Dec 2020 | 2.36B | 300.78M | 24.47 | 292.6M | 3.48B | 958.49M | 2.70 |
| 2019ended Dec 2019 | 2.05B | 141.09M | 11.48 | -30.22M | 2.89B | 890.36M | 6.00 |
| 2018ended Dec 2018 | 1.92B | 116.4M | 9.47 | 2.41M | 2.74B | 802.96M | 6.75 |
| 2017ended Dec 2017 | 1.65B | 175.39M | 14.27 | -280.1M | 2.71B | 756.94M | 1.25 |
| 2016ended Dec 2016 | 1.04B | 32.95M | 2.68 | 386.84M | 2.02B | 414.13M | 4.50 |
| 2015ended Dec 2015 | 966.23M | 82.97M | 6.75 | 118.76M | 1.26B | 275.8M | 4.50 |
| 2014ended Dec 2014 | 829.6M | 49.34M | 4.01 | 42.04M | 1.33B | 454.07M | 0.90 |
| 2013ended Dec 2013 | 712.03M | 81.2M | 6.61 | 97.71M | 1.11B | 280.2M | 0.90 |
| 2012ended Dec 2012 | 641.55M | 61.65M | 5.02 | 6.45M | 891.82M | 176.1M | 1.00 |
| 2011ended Dec 2011 | 592.45M | 50.97M | 4.15 | 100.02M | 809.73M | 175.51M | 1.00 |
| 2010ended Dec 2010 | 533.19M | 77.44M | 6.26 | 103.18M | 764.2M | 150.53M | 1.15 |
| 2009ended Dec 2009 | 381.94M | 65.33M | 5.64 | 23.74M | 709.98M | 227.1M | 1.20 |
| 2008ended Dec 2008 | 336.36M | 60.43M | 5.87 | -20.73M | 666.09M | 237.61M | 1.00 |
| 2007ended Dec 2007 | 275.43M | 41.14M | 3.63 | 17.22M | 422.24M | 100.57M | 1.14 |
| 2006ended Dec 2006 | 213.75M | 44.13M | 3.90 | 12.9M | 354.89M | 66.31M | 1.08 |
All figures in EGP, as reported in the company’s annual results; updated weekly.